Identification of annexin A1 as a proinvasive and prognostic factor for lung adenocarcinoma

Clinical and Experimental Metastasis

Volumn 28, Issue 5, 2011, Pages 413-425

  Liu, Ying Fu ^a   Zhang, Peng Fei ^b   Li, Mao Yu ^b   Li, Quo Qing ^b   Chen, Zhu Chu ^b  

^a XIAMEN UNIVERSITY   (China)

^b CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Annexin A1; Invasion; Lung adenocarcinoma; Prognostic factor; Proteomics

Indexed keywords

LIPOCORTIN 1; PROTEIN; SMALL INTERFERING RNA;

ADULT; ADVANCED CANCER; AGED; ARTICLE; CANCER CELL CULTURE; CANCER INVASION; CANCER RELAPSE; CANCER STAGING; CANCER SURVIVAL; CANCER TISSUE; DOWN REGULATION; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG ADENOCARCINOMA; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PROGNOSIS; PROTEIN EXPRESSION; UPREGULATION;

ADENOCARCINOMA; ADULT; AGED; ANNEXIN A1; FEMALE; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; SURVIVAL ANALYSIS; TUMOR CELLS, CULTURED; TUMOR MARKERS, BIOLOGICAL;

EID: 79955524322     PISSN: 02620898     EISSN: 15737276     Source Type: Journal    
DOI: 10.1007/s10585-011-9380-1     Document Type: Article

References (37)

1. AG Little, et al. 2007 National survey of non-small cell lung cancer in the United States: epidemiology, pathology and patterns of care Lung Cancer 57 3 253 260 17451842 10.1016/j.lungcan.2007.03.012 (Pubitemid 47285417)
2. ML Liao, et al. 2007 Incidence, time trend, survival, and predictive factors of lung cancer in Shanghai populations Zhonghua Yi Xue Za Zhi 87 27 1876 1880 17923007
3. Jemal A et al. (2006) Cancer statistics, 2006. CA Cancer J Clin 56(2):106-30
4. A Giese, et al. 2003 Cost of migration: invasion of malignant gliomas and implications for treatment J Clin Oncol 21 8 1624 1636 12697889 10.1200/JCO.2003.05.063 1:STN:280:DC%2BD3s7nvFWitw%3D%3D (Pubitemid 46594118)
5. EC Woodhouse RF Chuaqui LA Liotta 1997 General mechanisms of metastasis Cancer 80 8 Suppl 1529 1537 9362419 10.1002/(SICI)1097-0142(19971015)80: 8+<1529::AID-CNCR2>3.0.CO;2-F 1:STN:280:DyaK1c%2Fis1OnsA%3D%3D (Pubitemid 27444024)
6. EC Kohn 1993 Development and prevention of metastasis Anticancer Res 13 6B 2553 2559 7510940 1:STN:280:DyaK2c7ot1yqsw%3D%3D (Pubitemid 24103305)
7. IJ Fidler ML Kripke 1977 Metastasis results from preexisting variant cells within a malignant tumor Science 197 4306 893 895 887927 10.1126/science.887927 1:STN:280:DyaE2s3js1Sgsw%3D%3D (Pubitemid 8168759)
8. PS Steeg, et al. 1988 Evidence for a novel gene associated with low tumor metastatic potential J Natl Cancer Inst 80 3 200 204 3346912 10.1093/jnci/80.3.200 1:CAS:528:DyaL1cXktVWltLg%3D
9. JJ Chen, et al. 2001 Global analysis of gene expression in invasion by a lung cancer model Cancer Res 61 13 5223 5230 11431363 1:CAS:528: DC%2BD3MXltVCjs74%3D (Pubitemid 32681557)
10. G Van den Bergh L Arckens 2004 Fluorescent two-dimensional difference gel electrophoresis unveils the potential of gel-based proteomics Curr Opin Biotechnol 15 1 38 43 15102464 10.1016/j.copbio.2003.12.001 (Pubitemid 38224247)
11. JX Yan, et al. 2002 Fluorescence two-dimensional difference gel electrophoresis and mass spectrometry based proteomic analysis of Escherichia coli Proteomics 2 12 1682 1698 12469338 10.1002/1615-9861(200212)2:12<1682:: AID-PROT1682>3.0.CO;2-Y 1:CAS:528:DC%2BD3sXht1WnsQ%3D%3D (Pubitemid 36015504)
12. M Di Rosa, et al. 1984 Anti-phospholipase proteins Prostaglandins 28 4 441 442 6240666 10.1016/0090-6980(84)90232-6 1:CAS:528:DyaL28XkslOisw%3D%3D
13. BP Wallner, et al. 1986 Cloning and expression of human lipocortin, a phospholipase A2 inhibitor with potential anti-inflammatory activity Nature 320 6057 77 81 2936963 10.1038/320077a0 1:CAS:528:DyaL28XhvVWjur4%3D (Pubitemid 16105252)
14. V Gerke SE Moss 2002 Annexins: from structure to function Physiol Rev 82 2 331 371 11917092 1:CAS:528:DC%2BD38XjtFOns7c%3D (Pubitemid 34654456)
15. U Rescher V Gerke 2004 Annexins-unique membrane binding proteins with diverse functions J Cell Sci 117 Pt 13 2631 2639 15169834 10.1242/jcs.01245 1:CAS:528:DC%2BD2cXlvFehtrs%3D (Pubitemid 38997247)
16. FM Brichory, et al. 2001 An immune response manifested by the common occurrence of annexins I and II autoantibodies and high circulating levels of IL-6 in lung cancer Proc Natl Acad Sci U S A 98 17 9824 9829 11504947 10.1073/pnas.171320598 1:CAS:528:DC%2BD3MXmtlCmsLw%3D (Pubitemid 32769388)
17. KL Wang, et al. 2006 Expression of Annexin A1 in Esophageal and Esophagogastric Junction Adenocarcinomas: Association with Poor Outcome Clin Cancer Res 12 15 4598 4604 16899607 10.1158/1078-0432.CCR-06-0483 1:CAS:528:DC%2BD28XnvVGks78%3D (Pubitemid 44297810)
18. LH Lim S Pervaiz 2007 Annexin 1: the new face of an old molecule Faseb J 21 4 968 975 17215481 10.1096/fj.06-7464rev 1:CAS:528:DC%2BD2sXksVSqt7k%3D (Pubitemid 46495688)
19. K Emoto, et al. 2001 Annexin II overexpression correlates with stromal tenascin-C overexpression: a prognostic marker in colorectal carcinoma Cancer 92 6 1419 1426 11745218 10.1002/1097-0142(20010915)92:6<1419::AID- CNCR1465>3.0.CO;2-J 1:STN:280:DC%2BD3MnpsFKisA%3D%3D (Pubitemid 32947825)
20. YX Yang, et al. 2006 Proteome analysis of multidrug resistance in vincristine-resistant human gastric cancer cell line SGC7901/VCR Proteomics 6 6 2009 2021 16525997 10.1002/pmic.200402031 1:CAS:528:DC%2BD28XjtlKmtL8%3D
21. F Yang, et al. 2007 Identification of tumor antigens in human lung squamous carcinoma by serological proteome analysis J Proteome Res 6 2 751 758 17269731 10.1021/pr0602287 1:CAS:528:DC%2BD28XhtlGku7rK (Pubitemid 46340178)
22. A-L Cheng, et al. 2008 Identification of Novel Nasopharyngeal Carcinoma Biomarkers by Laser Capture Microdissection and Proteomic Analysis Clin Cancer Res 14 2 435 445 18223218 10.1158/1078-0432.CCR-07-1215 1:CAS:528: DC%2BD1cXhtVKitbo%3D (Pubitemid 351226111)
23. T Tian, et al. 2007 Determination of metastasis-associated proteins in non-small cell lung cancer by comparative proteomic analysis Cancer Sci 98 8 1265 1274 17537172 10.1111/j.1349-7006.2007.00514.x 1:CAS:528: DC%2BD2sXosV2ltbY%3D (Pubitemid 46993548)
24. GC Chang, et al. 2006 Identification of alpha-enolase as an autoantigen in lung cancer: its overexpression is associated with clinical outcomes Clin Cancer Res 12 19 5746 5754 17020980 10.1158/1078-0432.CCR-06-0324 1:CAS:528:DC%2BD28XhtVartbvJ (Pubitemid 44629605)
25. G Chen, et al. 2003 Protein profiles associated with survival in lung adenocarcinoma Proc Natl Acad Sci U S A 100 23 13537 13542 14573703 10.1073/pnas.2233850100 1:CAS:528:DC%2BD3sXptFOit7s%3D (Pubitemid 37444777)
26. K Arai, et al. 2001 Immunohistochemical investigation of S100A9 expression in pulmonary adenocarcinoma: S100A9 expression is associated with tumor differentiation Oncol Rep 8 3 591 596 11295086 1:CAS:528: DC%2BD3MXjsVSitLw%3D (Pubitemid 33758460)
27. W El-Rifai, et al. 2002 Gastric cancers overexpress S100A calcium-binding proteins Cancer Res 62 23 6823 6826 12460893 1:CAS:528:DC%2BD38XpsVahsrc%3D (Pubitemid 35424067)
28. A Hermani, et al. 2005 Calcium-binding proteins S100A8 and S100A9 as novel diagnostic markers in human prostate cancer Clin Cancer Res 11 14 5146 5152 16033829 10.1158/1078-0432.CCR-05-0352 1:CAS:528:DC%2BD2MXmt12qtb0%3D (Pubitemid 41003699)
29. G Oremek, et al. 2007 The significance of TU M2-PK tumor marker for lung cancer diagnostics Klin Med (Mosk) 85 7 56 58 1:CAS:528:DC%2BD2sXhtFKhtLvP
30. HR Hathurusinghe KS Goonetilleke AK Siriwardena 2007 Current status of tumor M2 pyruvate kinase (tumor M2-PK) as a biomarker of gastrointestinal malignancy Ann Surg Oncol 14 10 2714 2720 17602267 10.1245/s10434-007-9481-x (Pubitemid 47460645)
31. R Weinberger, et al. 2007 The pyruvate kinase isoenzyme M2 (Tu M2-PK) as a tumour marker for renal cell carcinoma Eur J Cancer Care (Engl) 16 4 333 337 10.1111/j.1365-2354.2006.00753.x 1:STN:280:DC%2BD2szntFyhsA%3D%3D
32. AS Ahmed, et al. 2007 M2-PK as a novel marker in ovarian cancer. A prospective cohort study Eur J Gynaecol Oncol 28 2 83 88 17479666 1:STN:280:DC%2BD2s3nt1GltQ%3D%3D (Pubitemid 46697775)
33. ZG Chen 2007 Exploration of metastasis-related proteins as biomarkers and therapeutic targets in the treatment of head and neck cancer Curr Cancer Drug Targets 7 7 613 622 18045066 10.2174/156800907782418301 1:CAS:528: DC%2BD1cXhsVGntg%3D%3D (Pubitemid 350074964)
34. L Liang L Qu Y Ding 2007 Protein and mRNA characterization in human colorectal carcinoma cell lines with different metastatic potentials Cancer Invest 25 6 427 434 17882654 10.1080/07357900701512258 1:CAS:528: DC%2BD2sXhtVGktbfI (Pubitemid 47450672)
35. T Tomonaga, et al. 2004 Identification of Altered Protein Expression and Post-Translational Modifications in Primary Colorectal Cancer by Using Agarose Two-Dimensional Gel Electrophoresis Clin Cancer Res 10 6 2007 2014 15041719 10.1158/1078-0432.CCR-03-0321 1:CAS:528:DC%2BD2cXisVGlu7g%3D (Pubitemid 38375560)
36. BA Babbin, et al. 2006 Annexin I regulates SKCO-15 cell invasion by signaling through formyl peptide receptors J Biol Chem 281 28 19588 19599 16675446 10.1074/jbc.M513025200 1:CAS:528:DC%2BD28Xms1Gqsb4%3D (Pubitemid 44035462)
37. Z Dai, et al. 2006 Identification and analysis of altered alpha1, 6-fucosylated glycoproteins associated with hepatocellular carcinoma metastasis Proteomics 6 21 5857 5867 17068759 10.1002/pmic.200500707 1:CAS:528: DC%2BD28Xht1yqsbbI (Pubitemid 44764022)